TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
UTMD

Utah Medical Products Inc

Healthcare · Medical Instruments & Supplies

74.20$ +0.6% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Utah Medical Products Inc (UTMD)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 87.3% of the shares are freely tradable; institutional investors hold 75.1%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 75.1%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 7.2%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 87.3%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 6.4%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 3Mio.

Largest Shareholders

Institutions

Institutions UTMD
Name Stake (%) Shares Change (%) Date
Brandes Investment Partners & Co 14.92 475,158 +5.8 06/30/2026
Dimensional Fund Advisors, Inc. 6.24 198,817 +0.5 06/30/2026
BlackRock Inc 5.89 187,649 +1.7 03/31/2026
Renaissance Technologies Corp 5.78 184,114 -4.9 03/31/2026
Vanguard Capital Management, LLC 4.35 138,560 +0.0 03/31/2026
Geode Capital Management, LLC 3.77 120,097 +36.8 03/31/2026
Minerva Advisors LLC 2.94 93,615 +0.0 06/30/2026
Hotchkis & Wiley Capital Management LLC 2.80 89,131 -18.2 03/31/2026

Funds

Funds UTMD
Name Stake (%) Shares Change (%) Date
Brandes Small Cap Value R6 6.87 218,681 +5.1 06/30/2026
Vanguard MStar Total Stk Mkt Idx Invest 3.07 97,788 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?